TRVI - CIK 0001563880
As of 2026-06-11, Trevi Therapeutics, Inc. (TRVI) has a market capitalization of $1.95 B, making it the #2125 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-11 | $1.95 B |
| 2026-06-10 | $1.90 B |
| 2026-05-29 | $2.03 B |
| 2026-05-28 | $2.05 B |
| 2026-05-26 | $2.04 B |
| 2026-05-25 | $2.01 B |
| 2026-05-24 | $2.01 B |
| 2026-05-22 | $2.01 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-11, Trevi Therapeutics, Inc. (TRVI) has a market capitalization of $1.95 B, making it the #2125 most valuable US-listed company.
Trevi Therapeutics, Inc. is the #2125 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.